Literature DB >> 11053092

The role of angiogenesis in rheumatoid arthritis: recent developments.

A E Koch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053092      PMCID: PMC1766630          DOI: 10.1136/ard.59.suppl_1.i65

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  100 in total

1.  Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions.

Authors:  G O Aspinall; M A Monteiro
Journal:  Biochemistry       Date:  1996-02-20       Impact factor: 3.162

Review 2.  Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border.

Authors:  G D Yancopoulos; M Klagsbrun; J Folkman
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

3.  Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin.

Authors:  S Gately; P Twardowski; M S Stack; M Patrick; L Boggio; D L Cundiff; H W Schnaper; L Madison; O Volpert; N Bouck; J Enghild; H C Kwaan; G A Soff
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

4.  4A11, a monoclonal antibody recognizing a novel antigen expressed on aberrant vascular endothelium. Upregulation in an in vivo model of contact dermatitis.

Authors:  A E Koch; B J Nickoloff; J Holgersson; B Seed; G K Haines; J C Burrows; S J Leibovich
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

5.  Angiostatin induces and sustains dormancy of human primary tumors in mice.

Authors:  M S O'Reilly; L Holmgren; C Chen; J Folkman
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

6.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

7.  Inhibition of neovascularization by a cartilage factor.

Authors:  K E Kuettner; B U Pauli
Journal:  Ciba Found Symp       Date:  1983

8.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

9.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

10.  Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.

Authors:  E M Paleolog; S Young; A C Stark; R V McCloskey; M Feldmann; R N Maini
Journal:  Arthritis Rheum       Date:  1998-07
View more
  29 in total

Review 1.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet's disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis.

Authors:  Hakan Erdem; Salih Pay; Muhittin Serdar; Ismail Simşek; Ayhan Dinç; Uğur Muşabak; Aysel Pekel; Mustafa Turan
Journal:  Rheumatol Int       Date:  2004-11-03       Impact factor: 2.631

3.  Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review).

Authors:  Lena J Gamble; Anton V Borovjagin; Qiana L Matthews
Journal:  Exp Ther Med       Date:  2010-03       Impact factor: 2.447

Review 4.  Putative effects of potentially anti-angiogenic drugs in rheumatic diseases.

Authors:  Nicola Maruotti; Francesco Paolo Cantatore; Domenico Ribatti
Journal:  Eur J Clin Pharmacol       Date:  2013-11-07       Impact factor: 2.953

5.  Angiogenesis blockade as a new therapeutic approach to experimental colitis.

Authors:  Silvio Danese; Miquel Sans; David M Spencer; Ivy Beck; Fernando Doñate; Marian L Plunkett; Carol de la Motte; Raymond Redline; David E Shaw; Alan D Levine; Andrew P Mazar; Claudio Fiocchi
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

6.  Angiogenic and Arthritogenic Properties of the Soluble Form of CD13.

Authors:  Yuxuan Du; Chenyang Lu; Rachel L Morgan; William A Stinson; Phillip L Campbell; Ellen Cealey; Wenyi Fu; Nicholas J Lepore; Jonatan L Hervoso; Huadong Cui; Andrew G Urquhart; Jeffrey N Lawton; Kevin C Chung; David A Fox; Mohammad A Amin
Journal:  J Immunol       Date:  2019-06-12       Impact factor: 5.422

Review 7.  Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases.

Authors:  R L Wilder
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

8.  IL-6/sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system.

Authors:  Misato Hashizume; Naohiko Hayakawa; Miho Suzuki; Masahiko Mihara
Journal:  Rheumatol Int       Date:  2009-03-07       Impact factor: 2.631

9.  Celastrol and Its Role in Controlling Chronic Diseases.

Authors:  Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

10.  Contribution of synovial lining cells to synovial vascularization of the rat temporomandibular joint.

Authors:  Kayoko Nozawa-Inoue; Fumiko Harada; Jin Magara; Atsushi Ohazama; Takeyasu Maeda
Journal:  J Anat       Date:  2015-12-08       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.